AGP Executive Report
Last update: 7 hours agoDrug Approval: FDA approved Inovio’s Voceryq, the first plasmid-DNA immunotherapy for recurrent respiratory papillomatosis, a rare condition that can impair speech and breathing and often requires repeated surgery. Infectious Disease: Washington reported the first U.S. avian-flu death of 2026 in a person exposed to infected dairy cattle; officials say the risk to the public remains low. Biopharma Partnerships: Boehringer Ingelheim’s antibody-drug conjugate deal with Korean biotech AimedBio has entered Phase 1, with the first patient enrolled. Prevention & Care: Indian health leaders see wearables as a way to spot health changes earlier. A home heart-failure monitor that tracks leg swelling automatically also showed promise in reducing repeat events. Nutrition: Experts say people taking GLP-1 drugs should prioritize protein, fiber and hydration to help address reduced food intake and side effects.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
